Saturday, February 16, 2019

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Parenterally administered ascorbic acid modulates sepsis-induced inflammation and coagulation in experimental animal models. The objective of this randomized, double-blind, placebo-controlled, phase I trial was to determine the safety of intravenously ...

No comments:

Post a Comment